X4 Pharmaceuticals (XFOR) News
NASDAQ: XFORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.91+0.12 (+4.30%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
XFOR news summary
We found 2 recent headlines mentioning X4 Pharmaceuticals (XFOR): 2 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, XFOR is up 4.30% at $2.91. The most recent story, "X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest X4 Pharmaceuticals headlines
- X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion LeadersX4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that the Company will host a virtual Investor Day on Thursday,…GlobeNewswire
- X4 Strengthens Cash Position Ahead Of Key Phase 3 Milestones(RTTNews) - X4 Pharmaceuticals (XFOR) has secured a new senior secured debt facility of up to $150 million from K2 HealthVentures, strengthening its financial flexibility as it advances mavorixafor…NasdaqXFOR, ET